Introduction {#sec1_1}
============

Approximately half of the 50 million stroke survivors in the world rely on help provided by caregivers \[[@B1]\]. For patients with stroke, accurate predictions of whether they will be able to perform their basic daily living activities would be useful for optimising initial stroke treatment as well as for establishing treatment goals.

Of all cases of stroke, ischaemic stroke accounts for 70% in Asia and 85% in Europe \[[@B2],[@B3]\]. Many studies have been performed to predict ischaemic stroke prognosis \[[@B4],[@B5],[@B6],[@B7],[@B8]\]. Although cerebral cardioembolic and lacunar infarctions have been actively investigated for their frequencies \[[@B9],[@B10],[@B11]\], there have been few reports on cerebral infarction of unknown origin. Among patients with cerebral infarctions, those with infarctions of unknown origin account for 35-42% \[[@B12]\]. However, this percentage is expected to be higher when patients are hospitalised.

An autopsy study indicated that large atheromatous aortic plaques ≥4 mm in diameter were located near the aortic arch of the chest; these plaques might be involved in cerebral infarction of unknown origin \[[@B13]\]. Large plaques (≥4 mm) are known to be involved not only in first-ever cerebral infarction \[[@B14],[@B15],[@B16]\] but also in its recurrence, with an increased risk of death \[[@B17],[@B18]\].

The purpose of the present study was to evaluate the information obtained from transoesophageal echocardiography (TOE), particularly in association with aortic arch plaques (AAPs), as a factor in the prognosis of patients with first-ever cerebral infarction of unknown origin at admission.

Methods {#sec1_2}
=======

Study Population {#sec2_1}
----------------

This retrospective case series was based on an analysis of data collected from a stroke registry of patients admitted to the Department of Neurological Science at Nippon Medical School Hospital between June 2009 and September 2011 for cerebral ischaemic stroke excluding intermittent ischaemic attack. At a median of 12 h after admission, a total of 571 patients with cerebral ischaemic stroke underwent the following examinations as routine diagnostics: brain computed tomography or magnetic resonance imaging, including diffusion-weighted imaging, fluid-attenuated inversion recovery imaging, T2-weighted imaging, and magnetic resonance angiography. Carotid Doppler ultrasonography was performed with a 5- to 10-MHz annular array transducer connected to an ultrasound imaging system (LOGIQ S6; GE Medical Systems, Milwaukee, Wisc., USA). Furthermore, each patient underwent transthoracic echocardiography and electrocardiography. Brain infarction was diagnosed as an acute neurological event persisting for ≥24 h in association with focal hyperintensity on diffusion-weighted imaging.

Based on the results, we classified infarct origins according to the Trial of Org 10172 in Acute Stroke Treatment criteria \[[@B19]\]. The patients were divided into those with small-vessel occlusions (n = 96), those with large-artery atherosclerosis (n = 120), and those with cardiogenic embolisms (n = 153). Unusual causes of stroke were found in 16 patients: artery dissection (n = 8), air embolism (n = 3), and iatrogenic stroke due to coronary angiography (n = 5). The remaining patients (n = 186) were defined as having ischaemic stroke of unknown origin unless the stroke origin could not be classified due to lack of routine diagnostic information. In some patients (n = 37), TOE could not be performed because of absent consent or possible intolerability of the test. Some subjects (n = 10) were transferred elsewhere. We ultimately included a consecutive series of 149 patients who had first-ever strokes prior to the onset of cerebral infarction, i.e. prestroke independence equivalent to a modified Rankin Scale (mRS) score of ≤1.

Age, sex, risk factors, and TOE findings, including degrees of AAPs, were assessed in 149 patients with stroke. These clinical characteristics were then compared between the patients with mRS scores of ≤2 (good outcomes) and those with mRS scores of \>2 (poor outcomes). This study was performed in accordance with the Declaration of Helsinki. The patients and their families provided written informed consent to undergo TOE, which was approved by the Ethics Committee of Nippon Medical School Hospital. The National Institutes of Health Stroke Scale (NIHSS) score at admission strongly predicts the likelihood of patient recovery after stroke; a score of ≤6 at admission forecasts good recovery \[[@B20]\]. Therefore, we divided the patients into those with NIHSS scores of ≤6 and those with scores of \>6 at admission.

Risk Factor Analysis {#sec2_2}
--------------------

Hypertension, diabetes mellitus, and dyslipidaemia were diagnosed by internal medicine specialists. Hypertension was diagnosed if subjects were taking antihypertensive agents or had a systolic blood pressure of ≥140 mm Hg or diastolic blood pressure of ≥90 mm Hg. Diabetes mellitus was diagnosed if subjects were taking oral antihyperglycaemic agents or insulin or if their fasting blood glucose level was ≥7 mmol/l. Dyslipidaemia was diagnosed if subjects were taking dyslipidaemia medication or had a serum low-density lipoprotein cholesterol level of ≥3.62 mmol/l, a triglyceride level of ≥1.69 mmol/l, or a high-density lipoprotein cholesterol level of \<1.03 mmol/l. Smoking status was recorded as non-smoker, current smoker, or ex-smoker (if they had quit at least 6 months before). Coronary heart disease was recorded as ischaemic heart disease or a history of ischaemic heart disease. We additionally performed 24-hour electrocardiography Holter monitoring after admission in all the patients to diagnose intermittent atrial fibrillation. The estimated glomerular filtration rate (eGFR) was calculated from serum creatinine (Cr) on admission, and the patients were classified into two groups: the eGFR \<60 ml/min/1.73 m^2^ group or the eGFR ≥60 ml/min/1.73 m^2^ group. The eGFR was calculated using the following equation for Japanese patients \[[@B21]\]: eGFR (ml/min/1.73 m^2^) = 194 × Cr^-1.094^ × age−^0.287^.

Because the Modification of Diet in Renal Disease formula requires stable renal function, patients with acute kidney injury were excluded from this study.

Carotid Ultrasonography {#sec2_3}
-----------------------

A LOGIQ S6 (GE Medical Systems) device with a 9-MHz linear probe was used during hospitalisation. The examiner was provided no clinical information prior to testing. The patients were examined in the supine position in a darkened room with their head in a neutral position or slightly inclined. Longitudinal and cross-sectional images of the common and internal carotid arteries were evaluated to examine the intima media thickness (IMT) via Doppler or two-dimensional duplex sonography. The maximum IMT of the carotid artery was defined as the greater IMT in the common carotid artery or as far as the bifurcation of the internal and external carotid arteries. In the present study, atherosclerotic plaque was defined as an IMT of ≥1.1 mm, according to our previous study \[[@B22]\]. We actually examined the presence or absence of stenosis by routine carotid echography of the proximal internal carotid artery. Large-artery atherosclerosis was diagnosed if proximal internal carotid artery atherosclerosis of \>50% by North American Symptomatic Carotid Endarterectomy Trial criteria existed in the ipsilateral side of cerebral infarction, and this case was excluded, as seen in figure [1](#F1){ref-type="fig"}\[[@B23]\]. Internal carotid narrowing of haemodynamic significance (≥50%) also was defined as present if peak systolic velocities in the internal carotid artery were ≥150 cm/s \[[@B24]\]. Internal carotid artery stenosis (≥50%) of the contralateral internal carotid artery did not occur, while there were only few cases of mild carotid artery stenosis (30-50%). The maximal common carotid artery IMT measurement has already been shown to correlate well with cardiovascular risk in another study \[[@B25]\].

![Flowchart of TOE for the identification of stroke patients. Patients were excluded if they had small-vessel occlusion, large-artery atherosclerosis, cardiogenic embolism, or an unusual cause of stroke, or if they did not undergo TOE.](cee-0004-0092-g01){#F1}

TOE Study {#sec2_4}
---------

Awake patients underwent TOE via the LOGIQ S6 device (GE Medical Systems) with a 4- to 7-MHz wideband multiplanar probe. Lidocaine spray was applied, but the patients were not premedicated. Experienced sonographers conducted all examinations and recorded the findings on a Super-VHS videotape. After examination of the cardiac structures, including the presence of intracardiac thrombi, spontaneous echocontrast, patent foramen ovale (PFO), and atrial septal aneurysms, the transducer was gradually withdrawn to a location 20-35 cm from the incisors. The multiplanar probe was manipulated to provide appropriate views for axial and sagittal images throughout the aorta. The thickness of the plaques located in the aortic arch, which was defined as the portion of the aorta between the curve at the top of the descending aorta and the upper point of visibility, was determined by measuring the thickness of the intima media complex. AAPs ≥4 mm thick were defined as being large \[[@B26],[@B27],[@B28],[@B29],[@B30]\].

Statistical Analysis {#sec2_5}
--------------------

Numerical values are presented as means ± standard deviations (SDs). Baseline characteristics, vascular risk factors, and TOE findings were compared between the good and poor outcome groups. Data were statistically analysed using the χ^2^ test for categorical variables and the Kruskal-Wallis test for non-parametric variables. When the expected values were \<5, Fisher\'s exact test was used. Given that there were many independent variables, two-step regression strategies were pursued. First, forward stepwise regression was used with no forced independent variables unless otherwise mentioned, and p = 0.10 indicated the criteria for entry and removal. The logistic regression model included selected factors that were determined from the forward stepwise regression. All data were analysed using JMP software, version 9.02, for Windows (SAS Institute Japan Inc., Tokyo, Japan). All analyses were two-tailed, and p \< 0.05 was considered statistically significant \[[@B9]\].

Results {#sec1_3}
=======

Of the 571 patients, 149 who could undergo TOE were included in our retrospective analysis. Table [1](#T1){ref-type="table"} shows their baseline characteristics according to mRS scores 3 months later. Of the 149 patients with cerebral infarction of unknown origin at admission, 110 (73.8%) and 39 (26.2%) showed a good prognosis (mRS score ≤2) or a poor prognosis (mRS score \>2) 3 months later, respectively. Once stratified by sex, 62 and 69% of the male patients were included in the good or poor prognosis group, respectively. The mean age was 67.3 years in the good prognosis group and 68.6 years in the poor prognosis group. There were no significant differences in age or sex between the groups.

Among the risk factors, a history of diabetes was more frequently observed in the poor prognosis group (p = 0.009). The baseline NIHSS scores were 2.69 and 6.48 in the good and poor prognosis groups, respectively. Baseline NIHSS scores were significantly higher in the poor prognosis group (p \< 0.001). There were significantly more patients with baseline NIHSS scores of \>6 in the poor prognosis group than in the good prognosis group (36 vs. 8.1%; p \< 0.001). Although there was no significant difference in AAPs as an indicator of arteriosclerosis between the groups (good prognosis: 4.51 mm; poor prognosis: 5.14 mm), the number of patients with AAPs of ≥4 mm was significantly larger in the poor prognosis group than in the good prognosis group (74 vs. 54%; p = 0.036). There were no significant differences in PFO, carotid artery IMT \<1.1 mm, or statin usage between the good and poor prognosis groups (table [1](#T1){ref-type="table"}).

For the poor prognosis group, to estimate the risk factors for a poor outcome after 3 months, the following variables were selected for logistic regression analysis: age, sex, hypertension, diabetes, dyslipidaemia, intermittent atrial fibrillation, eGFR, baseline NIHSS score, PFO occurrence, AAPs, and carotid artery IMT. A baseline NIHSS score of \>6 \[odds ratio (OR) = 6.77; 95% confidence interval (CI): 2.59-18.8; p \< 0.001\] and AAPs of ≥4 mm (OR = 2.75; 95% CI: 1.19-0.91; p = 0.024) were the independent factors associated with poor prognosis (table [2](#T2){ref-type="table"}).

Discussion {#sec1_4}
==========

Here, we examined the factors associated with poor prognosis of first-ever cerebral infarction of unknown origin. For the factors associated with a poor prognosis after cerebral infarction, a systemic review by Veerbeek et al. \[[@B31]\] reported on age and NIHSS score at admission; this information was obtained from six high-quality studies \[[@B4],[@B5],[@B6],[@B7],[@B8],[@B32]\]. In our study, the bivariate analysis showed that diabetes, an NIHSS score of \>6 at admission, and AAPs of ≥4 mm were significantly and frequently combined in the poor prognosis group and that the NIHSS score at admission was significantly higher in the poor prognosis group. Arteriosclerosis of the aortic arch and PFO (factors obtained from TOE) were included in this analysis, and logistic analysis was conducted using these factors as well as age, sex, hypertension, diabetes, dyslipidaemia, history of current smoking, intermittent atrial fibrillation, eGFR \<60 ml/min/1.73 m^2^, baseline NIHSS score, and carotid artery IMT. As a result, although a significant association was found in the poor prognosis group with an NIHSS score of \>6 on admission and AAPs of ≥4 mm, there was no significant association with age. In general, age has not been a predictor of poor prognosis \[[@B4],[@B6],[@B32],[@B33]\].

Additionally, risk factors such as intermittent atrial fibrillation (which can cause cardiogenic embolism; 21.4% of all the subjects in this study) and PFO (which can cause cryptogenic stroke; 48.9% of all the subjects in this study) were not associated with prognosis. Earlier studies have also shown no association between atrial fibrillation and prognosis \[[@B5],[@B7],[@B33]\], and no reports have indicated an association between PFO and prognosis.

The present study, which used arteriosclerosis of the aortic arch and PFO as factors obtained from TOE, showed a significant association between large plaques and prognosis. An earlier autopsy study reported that large plaques (≥4 mm) were commonly found in the aortic arch of the chest in patients with cerebral infarction of unknown origin \[[@B13]\]. However, our study is the first to show that large plaques are related to patient prognosis after cerebral infarction of unknown origin. Thickening of the chest aortic arch (≥4 mm) is a clinical condition that has attracted attention because it has already been shown to be involved not only in first-ever cerebral infarction \[[@B14],[@B15],[@B16]\] but also in cerebral infarction recurrence \[[@B18]\], with an increased risk of death \[[@B17],[@B18]\].

Although the diagnostic criteria for aortogenic embolism have been completely established, cerebral infarction is believed to be associated with arteriosclerosis of the aortic arch (≥4 mm). One report stated that as arteriosclerosis of the aortic arch thickened and mobile aortic plaques became more prevalent, the number of multiple infarctions that significantly extended to multiple vascular regions increased \[[@B27]\]. Fujimoto et al. \[[@B34]\] reported that aortogenic embolism, cardiogenic embolism, and paradoxical cerebral embolism could easily cause multiple brain lesions, and that they accounted for 20-31% in a series of 270 patients with cortical or subcortical cerebral infarctions. Therefore, aortogenic embolism is likely to cause multiple brain lesions, although we cannot conclude with certainty at this time that aortogenic embolism influences the prognosis of cerebral infarction of unknown origin.

In a retrospective study of 486 patients treated with tissue plasminogen activator in a single institution, patients with paradoxical cerebral embolisms had a significantly lower frequency of poor outcomes at hospital discharge than patients with other forms of cerebral infarction \[[@B35]\]. This study examined tissue plasminogen activator treatment, but it is generally believed that patients with paradoxical cerebral embolisms have good prognoses. The reason for this belief is that thrombus clots within the deep venous system can be fibrin rich and freely soluble in patients with paradoxical cerebral embolisms \[[@B36],[@B37]\].

Naess et al. \[[@B38]\] reported that thrombolytic therapy was more effective in patients with intermittent atrial fibrillation than in those with chronic atrial fibrillation. It was suggested that thrombi might have been relatively recently formed in patients with intermittent atrial fibrillation, which might have caused early recanalisation, leading to a good short-term prognosis. In contrast, an embolus from the aortic wall is typically an atherosclerotic plaque consisting of a lipid pool, fibrous cap, smooth muscle cells, mononuclear cells, and calcifications \[[@B16],[@B39]\]. In particular, these emboli include high contents of lipids, mononuclear leucocytes, and macrophages \[[@B39]\]. Therefore, it might be difficult to achieve spontaneous dissolution and recanalisation in this type of embolus compared with so-called fibrin-rich thrombi.

Di Tullio et al. \[[@B17]\] enrolled 209 stroke-free subjects who were over the age of 50 years and available to undergo TOE. Thus, the incidental detection of plaques in the aortic arch or proximal descending aorta was not associated with future vascular events \[[@B40]\]. However, a retrograde flow in the distal aortic arch and descending aorta can connect with the left subclavian artery, left carotid artery, and brachiocephalic trunk (in this order), causing embolic stroke in these vascular territories \[[@B41],[@B42]\]. The degree of retrograde flow varies in a normal population and is enhanced by age and aortic valve insufficiency \[[@B41],[@B43]\]. In the present study, which focussed on cerebral infarction of unknown origin, embolic stroke could have been induced by some of the AAPs via retrograde flow.

Large AAPs ≥4 mm in thickness are associated with ischaemic stroke of unknown cause, stroke recurrence, and all vascular events \[[@B13],[@B17]\]. The complex morphologic features of AAPs, including mobile or ulcerated aortic plaques, have also been closely linked to cryptogenic stroke \[[@B17],[@B27],[@B44]\]. The numbers of cases of mobility and ulceration were only 2 (1.3%) and 7 (4.7%), respectively. However, mobility and ulceration can become risk factors for the occurrence and recurrence of brain infarction. Hypoechoic and irregularly shaped plaques can also cause stenosis, but the incidence thereof varies depending on the examiner, as well as on the echo apparatus used. However, these plaques account for approximately 9% of the total. Thus, these cases might have influenced the results of the present study.

This study has some limitations. First, the study was based on a cross-sectional design, and the subjects were classified as having a broad category of cerebral infarction of unknown origin. Another limitation was that patients with cerebral infarction of unknown origin in a conventional sense were not included in this study to prevent selection bias; they might have had cerebral infarctions caused by atrial fibrillation and PFO and were intentionally excluded from the TOE group. However, it was impossible to avoid a selection bias because not all the patients underwent TOE. Because this study was performed retrospectively, a prospective case-control study could answer the question of whether arteriosclerosis of the aortic arch contributes to cerebral infarction of unknown origin (and thus to prognosis).

It is important to obtain information about AAPs using TOE, which assists in predicting the prognoses of patients in whom cerebral infarction of unknown origin is diagnosed at admission. Despite these limitations, TOE is useful in establishing the clinical diagnostic criteria for aortogenic brain embolisms.
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###### 

Baseline characteristics of patients

                                        mRS score ≤2 (n = 110; 73.8%)   mRS score \>2 (n = 39; 26.2%)   p value
  ------------------------------------- ------------------------------- ------------------------------- ---------
  Age, years                            67.3±14.4                       68.6±13.5                       0.612
  Age \>70 years, n                     56 (51%)                        18 (46%)                        0.710
  Male, n                               68 (62%)                        27 (69%)                        0.444
  Hypertension, n                       72 (65%)                        29 (74%)                        0.327
  Diabetes mellitus, n                  28 (25%)                        19 (48%)                        0.009
  Dyslipidaemia, n                      62 (56%)                        26 (66%)                        0.343
  Current smoking, n                    36 (33%)                        17 (44%)                        0.246
  Coronary heart disease, n             14 (13%)                        6 (15%)                         0.784
  Intermittent atrial fibrillation, n   25 (23%)                        7 (18%)                         0.652
  eGFR, ml/min/1.73 m^2^                69.9±25.0                       70.4±23.0                       0.897
  eGFR ≤60 ml/min/1.73 m^2^, n          35 (32%)                        11 (28%)                        0.840
  Baseline NIHSS score                  2.69±3.00                       6.48±5.66                       \<0.001
  Baseline NIHSS score \>6, n           9 (8.1%)                        14 (36%)                        \<0.001
  PFO, n                                58 (53%)                        15 (38%)                        0.139
  AAPs, mm                              4.51±2.28                       5.14±2.51                       0.174
  AAPs ≥4 mm, n                         59 (54%)                        29 (74%)                        0.036
  Carotid artery IMT, mm                1.90±1.01                       1.78±0.73                       0.408
  Carotid artery IMT \>1.1 mm, n        81 (74%)                        28 (72%)                        0.835
  Statin usage, n                       15 (13%)                        6 (15%)                         0.792

Values denote means ± SD unless specified otherwise. The ×^2^ test, the two-tailed Fisher exact test, and the Kruskal-Wallis test were used for comparison.

###### 

Logistic regression analysis for poor outcome (mRS score \>2) at 3 months after ischaemic stroke

                    OR     95% CI      p value
  ----------------- ------ ----------- ---------
  NIHSS score \>6   6.77   2.59-18.8   \<0.001
  AAPs ≥4 mm        2.75   1.19-6.91   0.024

Logistic regression analysis based on the maximum likelihood ratio for age, sex, hypertension, diabetes mellitus, dyslipidaemia, smoking, coronary heart disease, intermittent atrial fibrillation, eGFR, NIHSS score, PFO, AAPs, and carotid artery IMT. Whole model test at p \< 0.0001.
